|
Æ÷Ƽ½ºÆÄÆ®³Ê½º |
¿Ü±¹°è Á¦¾à»ç Medical Advisor(»êºÎÀΰúÀÇ»ç) Ãʺù
¼¿ï ¸¶Æ÷±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
1³â¡è |
ä¿ë½Ã |
07.16 |
|
|
ºê·¹ÀÎÇãºê |
[ÇìµåÇåÆÃ]±Û·Î¹ú ¸ÞµðÄà Áø´ÜÀåºñ ȸ»ç-ÀÓ»ó °æ·ÂÀÚ Ã¤¿ë
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) ÀçÇÐ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
09.23 |
|
|
¿¡À̽ºÆÄÆ®³Ê½º |
¿ÜÀÚCRO-CRMä¿ë
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
5³â¡è |
ä¿ë½Ã |
02.18 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
ÆĶô¼¿ ÄÚ¸®¾Æ CRA ¸ðÁý
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
08.22 |
|
|
(ÁÖ)¾¾¾Ø¿¡½ºÄÚ¸®¾Æ |
CRA °æ·Â»ç¿ø ä¿ë/ ¿Ü±¹°è Á¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
3³â¡è |
ä¿ë½Ã |
02.18 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
ÆÄ·º¼¿ ÄÚ¸®¾Æ - Clinical Lead
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
4³â¡è |
ä¿ë½Ã |
09.20 |
|
|
ÆĶó°ïÄÁ¼³Æà |
CRM(Clinical Trials Manager)/¿Ü±¹°è Á¦¾àȸ»ç ÀÓ»ó°æ·ÂÀÚ
¼¿ï ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
05.31 |
|
|
(ÁÖ)ÄÚ¸®¾ÆÈÞ¸Õ¸®¼Ò½Ã½º |
µ¶¼º ¾à¸®ºÐ¾ß 5³â ÀÌ»ó
´ëÀü ÀüÁö¿ª | ´ëÇÐ(2~3³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
5³â¡è |
ä¿ë½Ã |
09.19 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
Clinical Lead (for Dedicated CRA) ¸ðÁý -ÆĶô¼¿ÄÚ¸®¾Æ
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
4³â¡è |
ä¿ë½Ã |
07.25 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
ÆÄ·º¼¿ ÄÚ¸®¾Æ - Clinical Lead
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
4³â¡è |
ä¿ë½Ã |
10.10 |
|
|
Áö¸à½º(ÁÖ) |
Áö¸à½º¢ß ¸ÞµðÄ®ÃÊÀ½ÆÄ»ç¾÷ºÎ Imaging SW engineer ¸ðÁý
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
½ÅÀÔ |
»ó½Ãä¿ë |
04.14 |
|
|
JC Econet |
¿Ü±¹ À¯¸íÁ¦¾àȸ»ç Medical Manager(Àü¹®ÀÇ)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.28 |
|
|
(ÁÖ)ºê·¹ÀÎÇãºê |
ÀÓ»ó½ÃÇè QA
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
03.15 |
|
|
Pharmax Ogilvy Healthworld |
Market Research Unit head (Â÷ºÎÀå±Þ)
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
4³â¡è |
ä¿ë½Ã |
02.21 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
Dedicated CRA ¸ðÁý -ÆĶô¼¿ÄÚ¸®¾Æ
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
07.02 |
|